uridine triphosphate has been researched along with Blood Pressure, High in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 3 (42.86) | 2.80 |
| Authors | Studies |
|---|---|
| Alonazi, A; Challiss, RAJ; Christofidou, E; Nash, CA; Wang, CH; Willets, JM | 1 |
| Katome, T; Kobayashi, T; Kojima, M; Matsumoto, T; Taguchi, K; Takayanagi, K | 2 |
| Caricati-Neto, A; da Silva, ED; de Magalhães Galvão, K; Garcia, AG; Jurkiewicz, A; Jurkiewicz, NH; Miranda-Ferreira, R; Rodrigues, JQ | 1 |
| Matsumoto, T; Tostes, RC; Webb, RC | 1 |
| Cook, AK; Edwards, B; Field, M; Imig, JD; Inscho, EW; Pollock, JS; Zhang, S; Zhang, Z; Zhao, X | 1 |
| Fink, GD; Galligan, JJ; Hess, MC; Miller, SB | 1 |
7 other study(ies) available for uridine triphosphate and Blood Pressure, High
| Article | Year |
|---|---|
GRK2 expression and catalytic activity are essential for vasoconstrictor/ERK-stimulated arterial smooth muscle proliferation.
Topics: Angiotensin II; Animals; Cell Proliferation; Cells, Cultured; G-Protein-Coupled Receptor Kinase 2; Hypertension; Muscle, Smooth, Vascular; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Uridine Triphosphate; Vasoconstrictor Agents | 2023 |
Impaired UTP-induced relaxation in the carotid arteries of spontaneously hypertensive rats.
Topics: Animals; Carotid Arteries; Furans; Hypertension; Piperidines; Purinergic P2Y Receptor Antagonists; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Tetrazoles; Uridine Triphosphate; Vasodilation | 2020 |
Extracellular Uridine Nucleotides-Induced Contractions Were Increased in Femoral Arteries of Spontaneously Hypertensive Rats.
Topics: Animals; Endothelium, Vascular; Extracellular Space; Femoral Artery; Hypertension; Male; Peripheral Arterial Disease; Potassium; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Uridine Diphosphate; Uridine Triphosphate; Vasoconstriction | 2021 |
Differential regulation of atrial contraction by P1 and P2 purinoceptors in normotensive and spontaneously hypertensive rats.
Topics: Adenosine Triphosphate; Animals; Calcium; Calcium Channel Blockers; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Dose-Response Relationship, Drug; Electric Stimulation; Heart Atria; Hypertension; Mitochondria; Myocardial Contraction; Nifedipine; Purinergic P1 Receptor Antagonists; Purinergic P2 Receptor Antagonists; Rats; Rats, Inbred SHR; Rats, Wistar; Receptors, Purinergic P1; Receptors, Purinergic P2; Ryanodine; Uridine Triphosphate | 2014 |
Alterations in vasoconstrictor responses to the endothelium-derived contracting factor uridine adenosine tetraphosphate are region specific in DOCA-salt hypertensive rats.
Topics: Adenosine Triphosphate; Animals; Aorta, Thoracic; Arteries; Basilar Artery; Desoxycorticosterone; Dinucleoside Phosphates; Disease Models, Animal; Dose-Response Relationship, Drug; Endothelium, Vascular; Femoral Artery; Hypertension; Male; Mesenteric Arteries; Purinergic P2 Receptor Agonists; Rats; Rats, Wistar; Receptors, Purinergic P2; Sodium Chloride, Dietary; Uridine Diphosphate; Uridine Triphosphate; Vasoconstriction; Vasoconstrictor Agents | 2012 |
Impaired Ca2+ signaling attenuates P2X receptor-mediated vasoconstriction of afferent arterioles in angiotensin II hypertension.
Topics: Adenosine; Adenosine Triphosphate; Angiotensin II; Animals; Arterioles; Blood Pressure; Calcium; Calcium Signaling; Homeostasis; Hypertension; Intracellular Membranes; Kidney; Male; Microcirculation; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Purinergic P2 Receptor Agonists; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A1; Receptors, Purinergic P2; Receptors, Purinergic P2X; Uridine Triphosphate; Vasoconstriction | 2005 |
Differential localization of P2 receptor subtypes in mesenteric arteries and veins of normotensive and hypertensive rats.
Topics: Adenosine Triphosphate; Algorithms; Animals; Desoxycorticosterone; Hypertension; Immunohistochemistry; Male; Mesenteric Arteries; Mesenteric Veins; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P2; Uridine Triphosphate; Vasoconstriction | 2001 |